Your session is about to expire
← Back to Search
Intensity-Modulated Radiotherapy for Prostate Cancer
Study Summary
This trial is testing a new, shorter course of radiation therapy for prostate cancer. They want to see if it is just as effective as the current standard of care, but with fewer side effects.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- My prostate cancer is at an intermediate risk level with specific PSA, Gleason score, or stage.My body size is too large for certain types of scans.My scans show my cancer has spread to nearby tissues or lymph nodes.My prostate symptoms are mild.My scans show cancer has spread to my bones.I cannot have gadolinium contrast due to health reasons.I have had radiation therapy to my pelvic area before.I have a history of inflammatory bowel disease.My prostate is smaller than 60cc.I am older than 18 years.I can carry out normal activities without significant restrictions.My prostate cancer has one main tumor larger than 0.5cm and up to two smaller tumors.I have had a urethral stricture in the past.I am unable to understand and agree to the study's procedures and risks.I have undergone hormone therapy for prostate cancer.My daily activity is significantly limited by my health.I have had surgery to remove part of my prostate.I have a history of long-term prostate inflammation.
- Group 1: MR Image Guided, Intensity-Modulated Radiotherapy
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is this experiment open to new participants at present?
"This clinical trial, which was first made public on August 28th 2017, is not currently accepting patients. However, according to clinicaltrials.gov there are 1,321 other studies actively recruiting individuals at this time."
Are there multiple sites administering this research in the state?
"Currently, there are 7 locations enrolling patients in this trial. These include Memorial Sloan Kettering Nassau (Uniondale) and Memorial Sloan Kettering Basking Ridge (Basking Ridge), as well as 5 additional medical sites."
To what extent could MR-based image-guided, intensity-modulated radiotherapy jeopardize a patient's health?
"Due to the limited evidence of safety and effectiveness, MR-based image-guided, intensity-modulated radiotherapy was rated a 1 on our team's scale."
Share this study with friends
Copy Link
Messenger